Kim WJ - Search Results

1

Methylator-induced, mismatch repair-dependent G2 arrest is activated through Chk1 and Chk2.

Adamson AW, Beardsley DI, Kim WJ, Gao Y, Baskaran R, Brown KD. Adamson AW, et al. Among authors: kim wj. Mol Biol Cell. 2005 Mar;16(3):1513-26. doi: 10.1091/mbc.e04-02-0089. Epub 2005 Jan 12. Mol Biol Cell. 2005. PMID: 15647386 Free PMC article.

2

ATM is activated in response to N-methyl-N'-nitro-N-nitrosoguanidine-induced DNA alkylation.

Adamson AW, Kim WJ, Shangary S, Baskaran R, Brown KD. Adamson AW, et al. Among authors: kim wj. J Biol Chem. 2002 Oct 11;277(41):38222-9. doi: 10.1074/jbc.M204409200. Epub 2002 Jul 31. J Biol Chem. 2002. PMID: 12151394 Free article.

3

The monofunctional alkylating agent N-methyl-N'-nitro-N-nitrosoguanidine triggers apoptosis through p53-dependent and -independent pathways.

Kim WJ, Beardsley DI, Adamson AW, Brown KD. Kim WJ, et al. Toxicol Appl Pharmacol. 2005 Jan 1;202(1):84-98. doi: 10.1016/j.taap.2004.06.009. Toxicol Appl Pharmacol. 2005. PMID: 15589979

4

N-methyl-N'-nitro-N-nitrosoguanidine activates cell-cycle arrest through distinct mechanisms activated in a dose-dependent manner.

Beardsley DI, Kim WJ, Brown KD. Beardsley DI, et al. Among authors: kim wj. Mol Pharmacol. 2005 Oct;68(4):1049-60. doi: 10.1124/mol.105.013888. Epub 2005 Jun 30. Mol Pharmacol. 2005. PMID: 15994368

5

N-methyl-N'-nitro-N-nitrosoguanidine activates multiple cell death mechanisms in human fibroblasts.

Lee MW, Kim WJ, Beardsley DI, Brown KD. Lee MW, et al. Among authors: kim wj. DNA Cell Biol. 2007 Sep;26(9):683-94. doi: 10.1089/dna.2007.0594. DNA Cell Biol. 2007. PMID: 17678437

6

MLH1- and ATM-dependent MAPK signaling is activated through c-Abl in response to the alkylator N-methyl-N'-nitro-N'-nitrosoguanidine.

Kim WJ, Rajasekaran B, Brown KD. Kim WJ, et al. J Biol Chem. 2007 Nov 2;282(44):32021-31. doi: 10.1074/jbc.M701451200. Epub 2007 Sep 5. J Biol Chem. 2007. PMID: 17804421 Free article.

7

Aberrant methylation of the ATM promoter correlates with increased radiosensitivity in a human colorectal tumor cell line.

Kim WJ, Vo QN, Shrivastav M, Lataxes TA, Brown KD. Kim WJ, et al. Oncogene. 2002 May 30;21(24):3864-71. doi: 10.1038/sj.onc.1205485. Oncogene. 2002. PMID: 12032824

8

Characterization of the novel amplified in breast cancer-1 (NABC1) gene product.

Beardsley DI, Kowbel D, Lataxes TA, Mannino JM, Xin H, Kim WJ, Collins C, Brown KD. Beardsley DI, et al. Among authors: kim wj. Exp Cell Res. 2003 Nov 1;290(2):402-13. doi: 10.1016/s0014-4827(03)00353-7. Exp Cell Res. 2003. PMID: 14567997

9

The ATM-SMC1 pathway is essential for activation of the chromium[VI]-induced S-phase checkpoint.

Wakeman TP, Kim WJ, Callens S, Chiu A, Brown KD, Xu B. Wakeman TP, et al. Among authors: kim wj. Mutat Res. 2004 Oct 4;554(1-2):241-51. doi: 10.1016/j.mrfmmm.2004.05.006. Mutat Res. 2004. PMID: 15450422

10

The ATM gene is a target for epigenetic silencing in locally advanced breast cancer.

Vo QN, Kim WJ, Cvitanovic L, Boudreau DA, Ginzinger DG, Brown KD. Vo QN, et al. Among authors: kim wj. Oncogene. 2004 Dec 16;23(58):9432-7. doi: 10.1038/sj.onc.1208092. Oncogene. 2004. PMID: 15516988

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,105 results

Search Page

Filters